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Abstract
The history of hyperbaric oxygen therapy (HBOT) makes for fascinating read-
ing. From pneumatic chambers and compressed air baths to empirical therapeutic 
applications during the nineteenth century, the impetus to scientific application of 
HBOT began in seeking solution for decompression sickness during various con-
struction ventures. French physiologist Paul Bert’s research was pathbreaking and 
provided a scientific explanation on the etiology of the “bends.” In 1908, JS Haldane’s 
experiments recommended staged decompression and made diving safe. In 1921, OJ 
Cunningham employed HBOT to treat hypoxia secondary to lung infections success-
fully. It was cardiac surgeon Ite Boerema who put HBOT on a solid footing with his 
open-heart surgery results in various pediatric cardiac conditions and rightly deserved 
the title of father of modern-day hyperbaric medicine. From 1937 onwards, HBOT 
research snowballed into treating a wide variety of diseases. In 1999, the Undersea and 
Hyperbaric Medical Society and Food and Drug Administration recognized the value 
of HBOT, and this led to its becoming a major tool in the armamentarium of clini-
cians, either as a primary or adjunctive therapy for a spectrum of diseases.
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1. Introduction
Since 4500 BC, breath-holding dives for mother-of-pearl, sea sponges, and coral 
was a distinct occupation. These free divers could hold their breath for extended 
periods of time, and their work was confined to waters less than 30 m (100 ft) 
deep. It was undoubtedly a hazardous occupation, and many of them succumbed 
to decompression sickness after rapid surfacing. Persian king Xerxes the Great 
(520–465 BC) employed divers to salvage sunken goods and treasures from the 
wrecks of Greek ships he had sunk in numerous battles at sea. Some of these dives 
were recorded to depths of 20–30 m and lasting 4 minutes at a time. The ancient 
Greek historians Herodotos and Pausanias wrote about a Greek hero named Scyllias 
from Scione, who used a reed and diving capsule made from animal skins to cut the 
mooring lines of enemy ships. Pausanias even taught his own daughter Hydna to 
dive. Alexander the Great (365–323 BC), under the advice of a reputed astronomer 
named Ethicus, dived into the Bosphorus straits in a bathysphere, accompanied by 
a dog, a cat, and a rooster, after entrusting the security of the hoisting chain to his 
most loyal mistress. Taking advantage of the moment, she chose to elope with her 
lover after casting the chain into the sea, abandoning Alexander and leaving him 
to figure out his escape on his own! In 300 BC, Aristotle described the ruptured 
eardrum as a complication of undersea diving.
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While living in Venice in the late fifteenth century, Leonardo da Vinci designed 
diving suits to enable divers cut holes in the hulls of invading ships, but none seem 
to have been developed or used [1].
In 1620, Dutch inventor Cornelis Jacobszoon Drebbel (1572–1633) designed a 
wooden diving boat, sealed against water by greased leather, to travel in the River 
Thames at a depth of around 4 m, from Westminster to Greenwich. Air was supplied 
by two tubes with floats to maintain one end above water [2]. In sixteenth century 
England and France, full diving suits made of leather were used to depths of 60 ft 
with air being pumped down from the surface with the aid of manual pumps.
The first documented use of hyperbaric therapy was in 1662, when a British 
clergyman and physician named Nathaniel Henshaw used a system of organ bellows 
with unidirectional valves to change the atmospheric pressure in a sealed cham-
ber called a domicilium (Figure 1). Without any scientific rationale whatsoever, 
Henshaw claimed that high air pressures would remedy acute conditions while 
lower pressures would yield salutary results in chronic disorders. His domicilium 
therapy was touted to improve digestion and prevent lung diseases by manipulating 
ambient pressures without increasing oxygen concentrations, as oxygen was not 
discovered until nearly a century later [2].
In 1690, Edmond Halley designed a diving bell ventilated with weighted barrels 
of air sent down from the surface. Employing this device, Halley, escorted by five of 
his close friends, undertook a dive to a depth of 60 ft in the River Thames in that bell 
and remained submerged at that depth for 90 minutes. Too heavy for salvage work, 
Halley made improvements to his bell, extending his underwater exposure time to 
over 4 hours. The first deep-sea diving suit was invented in 1819 by Augustus Siebe. 
It used compressed air supplied to the helmet for ease of movement underwater.
All of these early submersibles used ambient air and were called “pneumatic 
chambers” or “compressed air baths.”
2. The era of empirical HBOT/HBO spas
Nearly two centuries later, in the 1830s, there was a rebirth of interest in 
hyperbaric medicine in France. In 1834, the French physician Junod built a 
hyperbaric chamber designed by the steam engine inventor James Watt, who was 
well-versed in pressure physics. This appliance could generate a maximum of 4 
atmospheres pressure and used to treat pulmonary afflictions using pressures 
Figure 1. 
Henshaw and his domicilium.
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between 2 and 4 ATA. Junod referred to his treatment as “Le Bain d’air com-
primé” (the compressed air bath), and claimed that it increased circulation to 
the internal organs and the brain, resulting in feelings of well-being and better 
general health.
Taberie designed a spherical pneumatic chamber made of cast iron with two 
pipes, one to provide pressure from a hydraulic compressor run by steam and the 
other to allow for ventilation. Carpet covered the floor to conceal the pipes, and it 
featured an antechamber to allow the physician to enter and exit without disturbing 
the pressure. The passage was also used to stock books, newspapers, and drinks for 
the patients (Figure 2).
Lange had a cylindrical chamber constructed out of wrought iron, designed 
to accommodate four persons. The temperature of the compressed air within 
the chamber was lowered in two ways. The first employed a stream of cold water 
directed against the force pump and the supply pipes. The second method was by 
filling a cup-shaped space at the top of the chamber with cold water and allowing it 
to cascade down the sides to soak sheets of linen and cool the air by evaporation. In 
winter the chamber was kept at a comfortable temperature by heating. The chamber 
was also provided with a device for regulating the flow of the incoming air so that 
it entered in a steady stream (instead of a succession of puffs in earlier versions) by 
a force pump. The pressure was secured, as in Tabarie’s system, by regulating the 
inflow and outflow of the air (Figure 3).
Leibig’s pneumatic chamber was located at Dianabad in Reichenhall, Bavaria, 
Germany. This pneumatic chamber had three chambers, each one capable of accom-
modating three persons. One antechamber connected all three rooms, allowing 
the physician to enter and exit without affecting the ambient pressure. The ante-
chamber also acted as a large pressure regulator, preventing the patients from being 
affected by sudden surges of pressure. A ventilation pipe through an opening in the 
ceiling provided good ventilation (Figure 4). The temperature and pressures within 
each chamber could also be individually controlled [3].
In 1837, Pravaz built the largest hyperbaric chamber in Lyon, France, to seat 
12 patients and treat patients with pulmonary conditions including tuberculosis, 
laryngitis, tracheitis, and pertussis, as well as unrelated conditions such as cholera, 
Figure 2. 
Taberie’s pneumatic chamber.
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conjunctivitis, deafness, menorrhagia, and rickets. In 1855, Bertin wrote a book on 
compressed air therapy and even constructed his own hyperbaric chamber.
Compressed air therapy was first introduced into the USA by JL Corning in 
1871. In 1876, Kelly treated a patient in a “Compressed Air Bath Apparatus” having 
two locking plates operated from outside to seal pressures. In 1877, French surgeon 
Fontaine developed the first mobile hyperbaric operating theater. The high ambient 
pressure was claimed to facilitate the reduction of hernias and provide relief for 
patients with lung diseases. Over the next 3 months, 27 surgeries were successfully 
performed within this mobile hyperbaric chamber (Figure 5). Spurred by the 
results, Fontaine ventured to erect a mammoth hyperbaric surgical amphitheater 
to accommodate 300 patients in one sitting. This did not see the light of day as 
Fontaine died from an accident at the Pneumatic Institute to become the first physi-
cian to be martyred in the history of hyperbaric medicine [4].
In 1885, C Theodore Williams published his “Lectures on the Compressed Air Bath 
and its Uses in the Treatment of Disease” in the British Medical Journal, extolling the 
use of atmospheric air under different degrees of atmospheric pressure to treat dis-
eases. He remarked that this mode of therapy was among the most important advances 
in modern medicine and expressed astonishment at its being ignored in England [5].
Back in the USA, during the closing days of the World War I, Kansas-bavsed 
physician Orval J Cunningham built a hyperbaric chamber in 1921 at Lawrence, 
Kansas. He used the facility to treat victims of the Spanish influenza epidemic that 
Figure 3. 
Lange’s pneumatic chamber.
Figure 4. 
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swept North America. Noticing that people in the valley fared better than those 
living in the mountains, Cunningham theorized that atmospheric pressure or 
barometric factors were responsible for the higher mortality rates in those residing 
at higher elevations. He observed remarkable improvements in patients treated with 
HBO, especially those who were cyanotic and comatose. In 1923, heat from open 
gas burners warming the chambers in winter scorched the insulation and started a 
fire, but all patients were safely evacuated. In another incident, a mechanical failure 
caused a complete loss of pressure within the chamber and all patients died. This 
did not, however, deter Cunningham’s enthusiasm for hyperbaric air. He went on to 
treat diseases such as syphilis, hypertension, diabetes mellitus, and cancer, believ-
ing that anaerobic infections played a role in the etiology of all these afflictions. In 
1928, with the financial backing of Henry H. Timken, a roller bearing manufacturer 
and tycoon, Cunningham built the largest hyperbaric chamber in the world along 
the shores of Lake Erie in Cleveland, Ohio, at a cost of 1 million dollars. This “Steel 
Ball Hospital” or “Cunningham’s Sanitarium” was a five-story high steel sphere, 
64 ft in diameter with 60 rooms and weighing 900 tons. Each floor of this structure 
had 12 rooms, with all the amenities of a good hotel (Figures 6 and 7). The growing 
popularity of Cunningham’s treatments prompted the Bureau of Investigation of the 
American Medical Association (AMA) to request the doctor to validate his claims 
Figure 5. 
Fontaine’s mobile hyperbaric operation theater.
Figure 6. 
Cunningham’s hyperbaric hotel—outside and inside view.
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regarding the effectiveness of hyperbaric therapy. Cunningham refused to share the 
details or cooperate with the AMA, leading to his being labeled a quack and a fraud. 
The chamber was dismantled in 1937 and sold for scrap during World War II [6].
3. A historical account of decompression sickness and its treatment
In 1840, Charles Pasley, charged with the recovery of the sunken warship HMS 
Royal George, commented that, of those who made frequent dives, “not a man 
escaped the repeated attacks of rheumatism and cold.” In 1841, Trigger, a French 
mining engineer, used a pressure chamber to deliver workers to the bottom of the 
river to extract coal. In 1845, he reported that some of his miners complained of 
joint pains and nervous disorders after surfacing. The first recorded death from 
“caisson disease” (which later came to be known as decompression illness (DCI) or 
acute decompression sickness) occurred in 1859 during the building of the Royal 
Albert Bridge, a railway bridge in England spanning the River Tamar from Saltash 
to Plymouth. Several workers were taken ill after emerging from deep underground 
after long hours of work under high atmospheric pressure conditions. In 1871, 
during the construction of the Eads Bridge in St. Louis, 352 compressed air workers, 
including Alphonse Jaminet, the physician in charge, were employed. Thirty work-
ers developed serious conditions with 12 ending fatally. Jaminet himself suffered 
decompression sickness, and his personal description was the first such recorded. It 
was in 1873 that Andrew Smith first utilized the term “caisson disease” to describe 
110 cases of decompression sickness that occurred during construction of the 
Brooklyn Bridge. The project employed 600 compressed air workers, and recom-
pression treatment was not available on site. In 1882, during the Hudson tunnel 
construction in New York, every fourth worker died of bends until a recompression 
chamber was installed to treat the condition. Only three workers died of bends over 
the next 18 months.
Paul Bert, a French professor of physiology and a student of Claude Bernard, 
is considered the father of pressure physiology (Figure 8). In 1878, while working 
closely with Dr. Alphonse Gal, the first doctor to actually dive in order to study 
Figure 7. 
Cunningham’s hyperbaric hotel—exterior and interior views.
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how the body reacted underwater, Bert studied Gal’s reports on divers who became 
symptomatic or died while surfacing. He conducted a series of dog experiments, 
exposing them to 7–9¾ atmospheres and subjecting them to rapid decompres-
sion. A majority of them died and exhibited grossly distended bodies with their 
right heart chambers filled with gas. When decompression was done at slowly 
over 1–2 hours after exposure to similar pressures, none of the dogs succumbed. 
Applying Dalton’s and Henry’s gas laws, Bert concluded that too rapid a decom-
pression induced a pathophysiologic insult secondary to supersaturation of body 
tissues with nitrogen, causing the formation of nitrogen bubbles. He also went on to 
suggest that divers stop halfway to the surface to allow for slow decompression after 
a deep dive—what is now known as deep stops. Bert was also the first to describe 
oxygen toxicity at pressures in excess of 1.75 ATA. This adverse effect on the central 
nervous system came to be known as the “Paul Bert effect” [7, 8].
In 1908, Scottish physiologist John Scott Haldane conducted experiments at the 
Lister Institute of Preventive Medicine in London assisted by Lieutenant Guybon 
Damant of the Royal Navy, an expert diver and amateur scientist, and a physiologist 
Edwin Arthur Boycott. A herd of 85 goats was assembled, and the researchers put 
groups of up to eight goats inside compression chambers for specific periods of time. 
Pressures were then normalized before releasing the animals into the institute’s yard 
for observation. These studies confirmed that those goats decompressed by stages 
did not exhibit signs of the bends (Figure 9). Haldane then introduced the concept 
of half times—the time required for a particular tissue to become half saturated with 
a gas—and recommended staged decompression, especially at shallower depths. He 
prepared detailed practical dive tables for the Royal Navy to prevent acute decom-
pression sickness. These guidelines remained the foundation of all diving operations 
until 1956 [10]. Heinrich Drager was the first to explore the use of pressurized 
oxygen in decompression sickness (Figure 10). His protocols were put into practice 
by Behnke and Shaw, who used HBOT for treating decompression sickness in the 
late 1930s. They replaced oxygen in place of compressed air, and their work resulted 
in the use of the first nitrogen-oxygen mixtures and hyperbaric treatment being 
tailored to the severity of the injury [11]. In 1939, the US Navy began treating divers 
suffering decompression sickness with hyperbaric oxygen therapy. After World War 
II, the US military conducted extensive research in HBOT, and this expanded the 
existing knowledge about survivable pressures and popularized HBOT in the late 
1950s and early 1960s. In the 1980s, Paul Harch began an in-depth study of brain 
decompression illness (DCI) and evaluated divers with this disorder. He concluded 
that it was not residual gas that was being treated but ischemic brain injury. He 
Figure 8. 
Dr. Paul Bert (1883–1886).
Respiratory Physiology
8
went on to develop individualized treatment protocols for over 50 different chronic 
neurological disorders. Harch is considered to be the foremost authority in the use of 
HBOT and SPECT brain blood flow imaging in neurology [12–14]. In 1990, former 
microbiology professor Igor Gamow invented and patented the Gamow Bag that 
provided mountaineers with a mobile and effective method to treat high-altitude 
sickness. This bag is a single-place portable hyperbaric chamber, pressurized with a 
Figure 11. 
The Gamow Bag.
Figure 9. 
Bends in the foreleg of a goat after experiments performed by physiologist Haldane [9].
Figure 10. 
Drager and his recompression chamber.
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foot pump, to simulate a descent to 7000 ft (Figure 11). In 1992, Harch treated the 
first delayed decompression sickness, which led to the treating of “dementia pugilis-
tica” in boxers and cerebral palsy and autism in children [15].
4. Treating diseases with HBO
In 1937, Brazilians Ozorio de Almeida and Costa pioneered the use of HBOT 
in treating leprosy [16]. In the 1950s, Ite Boerema, a cardiac surgeon from the 
Netherlands, conceived the idea of “flooding” the body’s tissues with extra oxygen. 
Working with the help of the Royal Dutch Navy, Boerema conducted a series of 
animal experiments and operations within a hyperbaric oxygen chamber (Figure 12). 
These went off without a hitch and led to the installation of a large operating hyper-
baric chamber at the University of Amsterdam. Many children with congenital heart 
diseases like tetralogy of Fallot, transposition of great vessels, and pulmonic stenosis 
were operated in this facility with great success. Boerema mooted the concept of “Life 
without blood” using HBO, when dissolved oxygen sufficed to meet the entire body’s 
oxygen needs without the need for red cells or hemoglobin. Boerema is credited with 
being the father of modern-day hyperbaric medicine [17].
In 1955–1956, I Churchill-Davidson evaluated clinical trials on HBOT as a 
potentiator for radiation therapy in cancer patients at St. Thomas Hospital in 
London [18]. Public interest in hyperbaric oxygen therapy started to grow in the 
1960s after publicity about its use in treating President John F Kennedy’s sick 
infant. In 1961, a colleague of Boerema, W. H. Brummelkamp, published a paper on 
inhibition of anaerobic infections by HBOT [19]. In 1962, Smith and Sharp reported 
the enormous benefits of HBO in carbon monoxide poisoning. They recommended 
that all those having a verified carboxyhemoglobin level above 25% needed imme-
diate HBOT at 3 ATA for 90 minutes, followed by two or three more sessions for 
full recovery, making HBO very cost-effective [20]. Global interest in HBOT was 
rekindled by this finding, resulting in hyperbaric units being installed at many 
centers like Duke University, New York Mount Sinai Hospital, Presbyterian Hospital 
and Edgeworth Hospital in Chicago, Good Samaritan in Los Angeles, St. Barnabas 
Hospital in New Jersey, Harvard Children’s Hospital, and St. Luke’s Hospital in 
Milwaukee. In 1965, Perrins from the UK demonstrated the effectiveness of HBOT 
Figure 12. 
Dr. Boerema with children operated by him.
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Air or gas embolism
Carbon monoxide poisoning; cyanide poisoning; smoke inhalation
Clostridial myositis and myonecrosis (gas gangrene)
Crush injuries, compartment syndromes, and other acute traumatic peripheral ischemias
Decompression sickness
Enhancement of healing in selected problem wounds
Exceptional blood loss anemia
Intracranial abscess
Necrotizing soft tissue infections
Refractory osteomyelitis
Skin flaps and grafts (compromised)
Delayed radiation injury (soft tissue and bony necrosis)
Thermal burns
Table 1. 
UHMS- and FDA-approved indications for hyperbaric oxygen therapy.
in osteomyelitis [21]. In 1966, Saltzman and coworkers from the USA proved the 
effectiveness of HBOT in stroke patients [22].
In 1970, Boschetty and Cernoch of Czechoslovakia conducted a trial of HBOT for 
multiple sclerosis. In their series 15 out of 26 patients with multiple sclerosis showed 
improvement after HBOT at 2 atmospheres [23]. In 1971, Lamm of West Germany 
used HBOT for treatment of sudden deafness. It was shown that HBOT shortens 
the course of healing in high-pitch perception dysacusis by upregulating constitu-
tive nitric oxide synthase in the substructure of the cochlea [24]. In 1973, Thurston 
pioneered studies that showed lower mortality figures in patients with myocardial 
infarction treated with HBO. HBOT was shown to improve oxygen supply to the 
threatened heart and reduce the volume of infarct size and other major adverse out-
comes [25]. In 1972, Richard A Neubauer set up the Ocean Hyperbaric Neurologic 
Center in Lauderdale-by-the-Sea exclusively for HBOT in the management of vari-
ous central nervous system disorders. He mooted the concept of “idling” neurons 
capable of surviving for years or even decades after the original injury. He claimed 
that these injured neurons could be re-activated with HBOT and that the greater the 
number of idling neurons, the better would be the patient’s response to HBOT [26]. 
Neubauer was also the co-founder and executive director of the American College 
of Hyperbaric Medicine. After his death in 2007 at the age of 83, his clinical research 
center in Florida was renamed the Neubauer Hyperbaric Neurologic Center. In 1976, 
Hollbach and Wasserman determined that 1.5 ATA (atmospheres absolute) maxi-
mizes oxygen content and glucose metabolism in the brain [27].
In 1985, RE Marx and his colleagues observed that the rate of osteoradionecrosis was 
30%/patient in patients treated with penicillin alone while rates in those treated with 
HBO was only 5% [28]. In 1987, Jain successfully treated patients with paralytic stroke 
using HBOT [29, 30]. In 2002, a US Army study confirmed that HBOT repairs white 
matter damage in children with cerebral palsy. In 2005, Stoller of the USA treated the 
first case of a child with fetal alcohol syndrome using HBOT and with good outcome 
[31]. In 2006, Thom of the USA discovered that HBO causes stem cell mobilization [32]. 
In 2010, Godman discovered that HBOT activated 8101 genes, resulting in reduction of 
inflammation and increase in growth in body tissues [33, 34]. In 2011, Stoller treated 
the first retired National Football League (NFL) player for chronic traumatic encepha-
lopathy [35]. In 2012, Harch and his colleagues demonstrated that blast-induced post-
concussion syndrome and post-traumatic stress disorders responded to HBOT [15].
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The UHMS and FDA approved HBOT for treatment of conditions like autism, 
stroke, air embolism, ischemic limbs, split-thickness skin graft acceptance, failed 
grafts, flap survival and salvage, wound reepithelialization, acute thermal burns, 
etc. (Table 1) [36, 37].
Many patients do not respond to aggressive acid-suppressing medications. 
HBOT has a beneficial effect in patients with blunt duodenal trauma, duodenal 
ulcers, and indomethacin-/radiation-induced gastritis. This salubrious effect is 
mediated by decreased production of oxidative stress markers like tumor necrosis 
factor-alpha, interleukin-1beta, neopterin, myeloperoxidase, and malondialdehyde. 
HBOT is seen to improve the acid-neutralizing function of the stomach, normalize 
gastric motility, reduce the duodenum acidification, decrease edema, and improve 
the blood flow both in human and equine studies [38, 39]. These effects were also 
seen in cases of inflammatory bowel diseases like Crohn’s [40].
5. Landmark academic events in HBOT
In September 1961, the First International Congress on the clinical applica-
tions of hyperbaric oxygen was held in Amsterdam. The Second International 
Conference on HBO was held in Glasgow in September 1964, with detailed delib-
erations on various aspects of HBOT. In November 1965, the Third International 
Congress on HBOT was organized at the Duke University at Durham, North 
Carolina. The Fourth and Fifth International Congresses were held in Sapporo, 
Japan, and Vancouver, respectively, in 1969 and 1973. The University of 
Aberdeen, Scotland, hosted the sixth conference in August 1977. The subsequent 
International Congress was held in Moscow in 1981 and is an annual event 
thereafter. The deliberations during these academic forums threw fresh light on 
the basic physiology, oxygen toxicity, and therapeutic applications of HBO in 
human disease.
The Undersea Medical Society (it added hyperbaric to its name in 1986), an 
organization made up largely of naval and ex-navy physicians, was founded in 
1967 in the USA. It reviewed the indiscriminate and inappropriate use of the 
HBO chamber for a variety of medical conditions by practitioners searching for a 
“cure-all” therapy, tarnishing the credibility of hyperbaric medicine. This non-
profit organization, now known as the Undersea and Hyperbaric Medical Society 
(UHMS), set up a Committee on Hyperbaric Oxygen Therapy in the 1970s to 
systematically review all the available scientific evidence for HBOT and formulate 
absolute indications for HBOT. This was accepted by insurance providers, includ-
ing Medicare. The UHMS is committed to providing, promoting, developing, 
and raising the quality of care across the spectrum in scientific communication, 
life sciences, and clinical practices of hyperbaric medicine by promoting high 
standards of patient care and operational safety. It offers accreditation and certifi-
cate of competency and credibility and has over 2500 members in 50 countries. 
UHMS also awards board certification in Undersea and Hyperbaric Medicine 
through the American Board of Emergency Medicine (ABEM), the American 
Board of Preventive Medicine (ABPM), and fellowship training in Undersea and 
Hyperbaric Medicine.
In 1980, Dr. Richard A. Neubauer and Dr. William S. Maxfield formed the 
American College of Hyperbaric Medicine (ACHM) to foster the ethical advance-
ment and expansion of hyperbaric medicine. The International Society of 
Hyperbaric Medicine was founded in 1988.
Hyperbaric medicine was approved by the American Board of Medical 
Specialties as a sub-specialty of emergency and preventative medicine in 2000.
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6. Developments in HBOT chambers
In 1860, the first hyperbaric chamber in the North American continent was 
constructed in Oshawa, Ontario, Canada. A year later, a neurologist, James Leonard 
Corning, built the first hyperbaric chamber in the USA in New York. This chamber 
was used to treat “nervous and related disorders.” The first decompression chamber 
was invented by the Italian engineer Alberto Gianni in 1916 [39, 40]. In 1928, the 
Harvard Medical School built a hyperbaric chamber for medical research. Among 
the largest HBOT chambers is the 22 ton 32 ft wide 14 ft wide one at the Utah Valley 
Regional Medical Center, USA.
In modern times, many traditional hard-shell hyperbaric chambers and soft-
shell, portable hyperbaric chambers (Figure 13–18) are manufactured by several 
companies and available in every major city. The latest chambers must comply 
with NFPA-992012 Edition Chapter 14 Code in the USA and European 1997 CEN 
pressure vessels 97/23E standards as well as the 1998 ECHM recommendations 
for safety. The newer chambers feature hingeless pressure-sealed doors, antifric-
tion bearings, antibacterial leather upholstery, and high-quality resin fiber loop 
mattresses and pillows that dissipate heat and moisture generated by the body 
during therapy. The newer low-pressure monoplace chambers are portable and 
Figure 13. 
The evolution of hyperbaric chambers.
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less expensive. Operating between 1.2 and 1.3 ATA pressures, they are eminently 
suited for use in homes and spas and also find use to improve results after plastic 
surgery.
The earliest documentation of therapeutic use of HBOT in animals was in 1998. 
The Veterinary Hyperbaric Medicine Society was formed in 2006. Veterinary-
specific hyperbaric chambers are available.
Figure 14. 
Monoplace HBO chamber.
Figure 15. 
Recompression chamber.
Figure 16. 
Multiplace HBOT chamber.
Figure 17. 
Hyperbaric operation suite.
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The evolution of HBOT chambers over time is chronicled in Figure 13.
7. Current status of HBOT
HBOT was called the Cinderella of modern medicine since it was not taught in 
medical schools and had no pharmaceutical companies to nurture and protect it. 
Over the course of time, it has shed the label of being a mysterious therapy and 
become a major tool in the armamentarium of clinicians either as a primary or 
adjunctive therapy for a spectrum of diseases. Stroke, cancer, heart disease, and 
chronic lung disease account for almost 60% of the total number of deaths. Hypoxia 
is a significant component of the pathology of these conditions, and this leads to 
metabolic acidosis, organ dysfunction, and death. Conventional oxygen therapy 
may not have desired results, when HBOT yields remarkable clinical improvement. 
HBOT prevents 75 percent of all major amputations that would otherwise be neces-
sary for diabetic wounds and a 450% increase in complete recovery in patients with 
traumatic brain injury receiving HBOT vs. standard intensive care. Newer applica-
tion of HBOT is in emergency care for resuscitation in cases of acute blood loss, 
near drowning, hanging and poisoning, and cardiorespiratory arrest.
Athletic associations like the NFL employ hyperbaric oxygen therapy as part of the 
recovery regimen for its athletes, and some players own their own HBOT chambers. Joe 
Namath experienced remarkable recovery from the head injuries he sustained during 
his career, leading him to be part of an FDA-approved study of HBOT at the Joe Namath 
Neurological Center of the Jupiter Medical Center in Florida. Ace swimmer Michael 
Phelps and football stars Maurice Jones-Drew and James Harrison have endorsed the 
benefits of HBOT, along with professional boxers like Evander Holyfield [41].
8. Conclusions
With the utilization of isotopic tracers, magnetic resonance imaging (MRI), and sin-
gle-photon emission computed tomography (SPECT), HBOT is getting evidence-based 
recognition. Various conditions like brain injuries, stroke, and neurological diseases 
with poor prognosis are now amenable to improved outcomes with the application of 
HBOT. There are more than 500 hyperbaric facilities in the USA alone. Much research 
Figure 18. 
Hyperbaric operation suite. (Image courtesy: CONE Health Wound Care and Hyperbaric Center, 
Greensboro, North Carolina, USA).
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remains to be done regarding the efficacy of HBO2 therapy to develop treatment plans 
for those in extremes of age. The use of hyperbaric medicine to treat wounds in the foot 
or in the brain is a divine gift, and great advances in this field are on the horizon. The 
future of healthcare is here!
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